Enable Injections, LLC
http://enableinjections.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Enable Injections, LLC
Device/Diagnostics Quarterly Deal Statistics, Q4 2016
Medtech companies raised $2.4 billion in the fourth quarter, the second-strongest of the year; Q4 device M&A deals totaled $9 billion in value, led by Allergan's $2.9 billion buy of Acelity's LifeCell division. Diagnostics financings finished out the year at $721 million, an increase over the previous quarter and 2016's second-highest quarter, but diagnostics M&A activity was the lowest of the year at $87 million, with only two completed acquisitions.
Start-Up Spotlight: Enable Injections, On-Body Biologics Delivery By Oreo-Sized Device
Enable Injections has developed a small wearable device that allows controlled delivery of biologic drugs – of small to potentially large volumes – while the patient continues with their daily life.
Deals Shaping The Medical Industry, March 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.
Company Information
- Industry
-
Pharmaceuticals
- Drug Delivery
-
Drug Delivery
- Controlled Release
-
Medical Devices
- Infusion Therapy Equipment and Supplies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice